Evotec CEO Wern­er Lan­thaler re­signs; Af­ter No­vo deal, ex-For­ma chief ush­ers in new era at Paci­ra

→ Wern­er Lan­thaler an­nounced his res­ig­na­tion as CEO of se­r­i­al Big Phar­ma part­ner Evotec on Wednes­day, and his for­mer COO Mario Poly­wka will fill in as in­ter­im chief un­til a per­ma­nent suc­ces­sor is named. Un­der Lan­thaler’s lead­er­ship, Evotec has formed al­liances with Take­da (RNA), Bris­tol My­ers Squibb (neu­ro dis­eases), Eli Lil­ly (meta­bol­ic dis­eases) and No­vo Nordisk (kid­ney dis­eases), among many oth­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER